This is the classic website, which will be retired eventually. Please visit the modernized ClinicalTrials.gov instead.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Neural and Metabolic Factors in Carbohydrate Reward (CARB)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT06053294
Recruitment Status : Recruiting
First Posted : September 25, 2023
Last Update Posted : September 28, 2023
Sponsor:
Information provided by (Responsible Party):
Alexandra DiFeliceantonio, Virginia Polytechnic Institute and State University

Brief Summary:
Dietary factors contributed to nearly 50% of all cardiometabolic deaths in the US in 2012, making it one of the leading causes of preventable death in the US, second only to tobacco use. Human diets and food choices can't help but be influenced by the ubiquitous availability of processed foods of high-energy density and low nutrient content, consumption of which can lead to obesity, type II diabetes, heart disease, and other types of metabolic dysfunction. Surprisingly, food reinforcement does not rely on perceived energy density. Rather food reinforcement is associated with actual energy density and therefore, on an implicit knowledge of caloric content. That implicit knowledge must have a neural signature and a mechanism by which the gut communicates nutritive value to the brain. There is evidence, at least for fat and carbohydrates, that these pathways are separable, but terminate in a common neural structure, the dorsal striatum or caudate. This could be one mechanism by which modern processed foods high in both fat and carbohydrate are so sought after and readily consumed, In fact, when experimentally tested, fat and carbohydrate combinations were more reinforcing calorie for calorie than fat or carbohydrates alone and the level of reinforcement correlated with activity in reward- related brain areas. Beyond simple reinforcing value, it is known from the literature on drugs of abuse that the faster a drug is arrives at the brain, the higher it's abuse potential, however, little is known about how the kinetics of nutrient excursion influence food preference, choice, and brain activity. This project aims to test this specifically for carbohydrate reward.

Condition or disease Intervention/treatment Phase
Carbohydrate Metabolism Other: CS- Beverage Other: CS+Fast Other: CS+Slow Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 64 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single (Participant)
Primary Purpose: Basic Science
Official Title: Neural and Metabolic Factors in Carbohydrate Reward: An Examination of Speed
Actual Study Start Date : May 1, 2023
Estimated Primary Completion Date : May 1, 2028
Estimated Study Completion Date : May 1, 2029

Arm Intervention/treatment
Experimental: CS- First
Participants who receive the conditional stimulus (CS) - first.
Other: CS- Beverage
Conditioned Stimulus - (CS-): Flavored beverage solution with sweetness-matched sucralose. Participants will consume flavored beverage solutions sweetened with sucralose to match the sweetness of 75 calories of sucrose in 6 exposure sessions within 1 week. One exposure session will include preand post-consumption blood draws over a 2-hour period, and one exposure session will include indirect calorimetry measurement pre- and post-consumption. The other 4 exposure sessions will occur at specified times outside the laboratory sessions. Subjective ratings of internal state (i.e., hunger, fullness, and thirst) will be collected throughout each exposure. Subjective ratings of liking and wanting of each beverage will also be assessed.

Other: CS+Fast
(CS+): Flavored beverage solution with 75 calories of sucrose. Participants will consume flavored beverage solutions containing 75 calories of sucrose in 6 exposure sessions within 1 week. One exposure session will include pre- and post-consumption blood draws over a 2-hour period, and one exposure session will include indirect calorimetry measurement preand post-consumption. The other 4 exposure sessions will occur at specified times outside the laboratory sessions. Subjective ratings of internal state (i.e., hunger, fullness, and thirst) will be collected throughout each exposure. Subjective ratings of liking and wanting of each beverage will also be assessed.

Other: CS+Slow
(CS+): Flavored beverage solution with 75 calories of maltodextrin and fiber. Participants will consume flavored beverage solutions containing 75 calories of maltodexrin in 6 exposure sessions within 1 week. One exposure session will include pre- and post-consumption blood draws over a 2-hour period, and one exposure session will include indirect calorimetry easurement preand post-consumption. The other 4 exposure sessions will occur at specified times outside the laboratory sessions. Subjective ratings of internal state (i.e., hunger, fullness, and thirst) will be collected throughout each exposure. Subjective ratings of liking and wanting of each beverage will also be assessed.

Experimental: CS+Fast First
Participants who receive the CS+Fast First
Other: CS- Beverage
Conditioned Stimulus - (CS-): Flavored beverage solution with sweetness-matched sucralose. Participants will consume flavored beverage solutions sweetened with sucralose to match the sweetness of 75 calories of sucrose in 6 exposure sessions within 1 week. One exposure session will include preand post-consumption blood draws over a 2-hour period, and one exposure session will include indirect calorimetry measurement pre- and post-consumption. The other 4 exposure sessions will occur at specified times outside the laboratory sessions. Subjective ratings of internal state (i.e., hunger, fullness, and thirst) will be collected throughout each exposure. Subjective ratings of liking and wanting of each beverage will also be assessed.

Other: CS+Fast
(CS+): Flavored beverage solution with 75 calories of sucrose. Participants will consume flavored beverage solutions containing 75 calories of sucrose in 6 exposure sessions within 1 week. One exposure session will include pre- and post-consumption blood draws over a 2-hour period, and one exposure session will include indirect calorimetry measurement preand post-consumption. The other 4 exposure sessions will occur at specified times outside the laboratory sessions. Subjective ratings of internal state (i.e., hunger, fullness, and thirst) will be collected throughout each exposure. Subjective ratings of liking and wanting of each beverage will also be assessed.

Other: CS+Slow
(CS+): Flavored beverage solution with 75 calories of maltodextrin and fiber. Participants will consume flavored beverage solutions containing 75 calories of maltodexrin in 6 exposure sessions within 1 week. One exposure session will include pre- and post-consumption blood draws over a 2-hour period, and one exposure session will include indirect calorimetry easurement preand post-consumption. The other 4 exposure sessions will occur at specified times outside the laboratory sessions. Subjective ratings of internal state (i.e., hunger, fullness, and thirst) will be collected throughout each exposure. Subjective ratings of liking and wanting of each beverage will also be assessed.

Experimental: CS+Slow First
Participants who receive the CS+Slow First
Other: CS- Beverage
Conditioned Stimulus - (CS-): Flavored beverage solution with sweetness-matched sucralose. Participants will consume flavored beverage solutions sweetened with sucralose to match the sweetness of 75 calories of sucrose in 6 exposure sessions within 1 week. One exposure session will include preand post-consumption blood draws over a 2-hour period, and one exposure session will include indirect calorimetry measurement pre- and post-consumption. The other 4 exposure sessions will occur at specified times outside the laboratory sessions. Subjective ratings of internal state (i.e., hunger, fullness, and thirst) will be collected throughout each exposure. Subjective ratings of liking and wanting of each beverage will also be assessed.

Other: CS+Fast
(CS+): Flavored beverage solution with 75 calories of sucrose. Participants will consume flavored beverage solutions containing 75 calories of sucrose in 6 exposure sessions within 1 week. One exposure session will include pre- and post-consumption blood draws over a 2-hour period, and one exposure session will include indirect calorimetry measurement preand post-consumption. The other 4 exposure sessions will occur at specified times outside the laboratory sessions. Subjective ratings of internal state (i.e., hunger, fullness, and thirst) will be collected throughout each exposure. Subjective ratings of liking and wanting of each beverage will also be assessed.

Other: CS+Slow
(CS+): Flavored beverage solution with 75 calories of maltodextrin and fiber. Participants will consume flavored beverage solutions containing 75 calories of maltodexrin in 6 exposure sessions within 1 week. One exposure session will include pre- and post-consumption blood draws over a 2-hour period, and one exposure session will include indirect calorimetry easurement preand post-consumption. The other 4 exposure sessions will occur at specified times outside the laboratory sessions. Subjective ratings of internal state (i.e., hunger, fullness, and thirst) will be collected throughout each exposure. Subjective ratings of liking and wanting of each beverage will also be assessed.




Primary Outcome Measures :
  1. Change in preference- liking [ Time Frame: at the end of the study; 5 weeks after start of study ]

    Subjective ratings of liking of flavors used in the intervention will be assessed at baseline and after the intervention.

    The generalized Labeled Magnitude Scale will be used. The scale is anchored by descriptors of "Most Disliked Sensation Imaginable" and "Most Liked Sensation Imaginable" at the lower and upper ends, respectively. The score is determined by the place on the scale participants select (range of scale is 0-100). An increase in score from baseline to post-intervention indicates an increase in liking.



Secondary Outcome Measures :
  1. Change in preference- wanting, rated [ Time Frame: at the end of the study; 5 weeks after start of study ]
    Subjective ratings of liking of flavors used in the intervention will be assessed at baseline and after the intervention. A Visual Analog Scale will be used. Participants select a place on the line that corresponds with their subjective rating, and the score is determined by the place selected (range of scores is 0-100). The line is anchored by polar opposite descriptors ("Do not want at all" and "Want very much"). An increase in score from baseline to post-intervention indicates and increase in wanting.

  2. Change in preference- wanting, ad lib intake [ Time Frame: at the end of the study; 5 weeks after start of study ]
    Ad libitum intake will be used as a measure of wanting in a post-test session. Participants will be provided each beverage used during the intervention and asked to drink as much or as little of them as they would like over a 30- minute period.

  3. Change in preference- wanting, forced choice [ Time Frame: at the end of the study; 5 weeks after start of study ]
    Forced choice will be used as a measure of wanting in a post-test session. Participants will be provided each of the beverages used during the intervention and asked to choose 1 to take home with them.

  4. Blood oxygen level-dependent (BOLD) response to beverages [ Time Frame: at the end of the study; 5 weeks after start of study ]
    In a post-test session, functional magnetic resonance imaging (fMRI) scans will be performed while beverages (without calories) used during the intervention are delivered through a custom manifold fitted to a head coil and connected to a pump system that allows precisely timed and measured delivery of liquids.

  5. Blood glucose response to beverages [ Time Frame: Each week for 3 weeks during the study ]
    Blood glucose will be assessed at baseline and at set time points for 1 hour after consumption of intervention beverages in one exposure session.

  6. Blood insulin response to beverages [ Time Frame: Each week for 3 weeks during the study ]
    Blood insulin will be assessed at baseline and at set time points for 2 hours after consumption of intervention beverages in an exposure session.

  7. Energy expenditure in response to beverages [ Time Frame: Each week for 3 weeks during the study ]
    Indirect calorimetry will be used to determine energy expenditure at baseline (for 30 minutes) and for 1 hour after consumption of intervention beverages in an exposure session.

  8. Respiratory exchange ratio in response to beverages [ Time Frame: Each week for 3 weeks during the study ]
    Indirect calorimetry will be used to determine respiratory exchange ratio at baseline (for 30 minutes) and for 1 hour after consumption of intervention beverages in an exposure session.

  9. Substrate oxidation in response to beverages [ Time Frame: Each week for 3 weeks during the study ]
    Indirect calorimetry will be used to determine substrate oxidation at baseline (for 30 minutes) and for 1 hour after consumption of intervention beverages in an exposure session.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 45 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. BMI between 18.5-30 kg/m2
  2. Not pregnant or planning to become pregnant during study participation
  3. Residing in the Roanoke area and/or willing/able to attend sessions at the Fralin Biomedical Research Institute
  4. Able to speak and write in English

Exclusion Criteria:

  1. Current inhaled nicotine use
  2. History of alcohol dependence.
  3. Current or past diagnosis of diabetes or thyroid problems.
  4. Glycated hemoglobin (Hemoglobin A1C) >5.7%
  5. Taking medications known to influence study measures (including antiglycemic agents, thyroid medications, sleep medications)
  6. Active medical or neurologic disorder.
  7. Current shift work (typical pattern of work/activity overnight)
  8. Previous weight loss surgery
  9. Adherence to a special diet within the past 3 months (e.g., low-carb or ketogenic diet, exclusion of food groups/specific macronutrients, intermittent fasting, etc.)
  10. Allergy to any food or ingredient included in the study diets, meals, or beverages
  11. Currently pregnant or planning to become pregnant during study participation
  12. Claustrophobia
  13. Contraindications for MRI, including pacemaker, aneurysm clips, neurostimulators, cochlear or other implants, metal in eyes, regular work with steel, etc.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT06053294


Contacts
Layout table for location contacts
Contact: Alexandra G DiFeliceantonio, PhD 5405262285 dife@vt.edu

Locations
Layout table for location information
United States, Virginia
Fralin Biomedical Research Institute at VTC Recruiting
Roanoke, Virginia, United States, 24016
Contact: Alexandra G DiFeliceantonio, PhD    540-526-2285    dife@vt.edu   
Sponsors and Collaborators
Virginia Polytechnic Institute and State University
Layout table for additonal information
Responsible Party: Alexandra DiFeliceantonio, Assitant Professor, Virginia Polytechnic Institute and State University
ClinicalTrials.gov Identifier: NCT06053294    
Other Study ID Numbers: 19-927
First Posted: September 25, 2023    Key Record Dates
Last Update Posted: September 28, 2023
Last Verified: September 2023

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No